CasInvent Pharma

CasInvent

This company develops selective casein kinase 1 inhibitors to treat resistant cancers, including leukaemias and solid tumours, for patients with limited treatment options.

Flindr Therapeutics

This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

tolremo

This company develops small molecule drugs to prevent non-genetic resistance in cancer patients receiving targeted therapies.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.

Stingray Bio

This company develops small molecule inhibitors of the LMTK3 kinase pathway for the treatment of breast and other cancers.